{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:31Z","timestamp":1786979611504,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00105-018-4312-5","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T02:26:01Z","timestamp":1542853561000},"page":"116-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["PAPA-Syndrom mit Morbus Crohn und prim\u00e4r sklerosierender Cholangitis\/Autoimmunhepatitis-Overlap-Syndrom","PAPA syndrome with Crohn\u2019s disease and primary sclerosing cholangitis\/autoimmune hepatitis overlap syndrome"],"prefix":"10.1007","volume":"70","author":[{"given":"Holger","family":"Sch\u00e4ffler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia","family":"Blattmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Findeisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix G.","family":"Meinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut","family":"Meyer-Bahlburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Steinm\u00fcller-Magin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Trauzeddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"4312_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","volume":"72","author":"NM Lindor","year":"1997","unstructured":"Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT (1997) A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72:611\u2013615. \n                    https:\/\/doi.org\/10.1016\/S0025-6196(11)63565-9","journal-title":"Mayo Clin Proc"},{"key":"4312_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/BOR.0000000000000314","volume":"28","author":"D Holzinger","year":"2016","unstructured":"Holzinger D, Roth J (2016) Alarming consequences\u2014autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1. Curr Opin Rheumatol 28:550\u2013559. \n                    https:\/\/doi.org\/10.1097\/BOR.0000000000000314","journal-title":"Curr Opin Rheumatol"},{"key":"4312_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2013.03.016","volume":"147","author":"A Almeida de Jesus","year":"2013","unstructured":"Almeida de Jesus A, Goldbach-Mansky R (2013) Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol 147:155\u2013174. \n                    https:\/\/doi.org\/10.1016\/j.clim.2013.03.016","journal-title":"Clin Immunol"},{"key":"4312_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","volume":"11","author":"CA Wise","year":"2002","unstructured":"Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961\u2013969","journal-title":"Hum Mol Genet"},{"key":"4312_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.semarthrit.2015.02.012","volume":"45","author":"E Lindwall","year":"2015","unstructured":"Lindwall E, Singla S, Davis WE, Quinet RJ (2015) Novel PSTPIP1 gene mutation in a\u00a0patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome. Semin Arthritis Rheum 45:91\u201393. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2015.02.012","journal-title":"Semin Arthritis Rheum"},{"key":"4312_CR6","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH (2009) Inflammatory bowel disease. N\u00a0Engl J Med 361:2066\u20132078. \n                    https:\/\/doi.org\/10.1056\/NEJMra0804647","journal-title":"N Engl J Med"},{"key":"4312_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00535-009-0138-3","volume":"45","author":"L Mayer","year":"2010","unstructured":"Mayer L (2010) Evolving paradigms in the pathogenesis of IBD. J\u00a0Gastroenterol 45:9\u201316. \n                    https:\/\/doi.org\/10.1007\/s00535-009-0138-3","journal-title":"J Gastroenterol"},{"key":"4312_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/ced.12585","volume":"40","author":"T Zeeli","year":"2015","unstructured":"Zeeli T, Padalon-Brauch G, Ellenbogen E, Gat A, Sarig O, Sprecher E (2015) Pyoderma gangrenosum, acne and ulcerative colitis in a\u00a0patient with a\u00a0novel mutation in the PSTPIP1 gene. Clin Exp Dermatol 40:367\u2013372. \n                    https:\/\/doi.org\/10.1111\/ced.12585","journal-title":"Clin Exp Dermatol"},{"key":"4312_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/bjd.14383","volume":"175","author":"X Calder\u00f3n-Castrat","year":"2016","unstructured":"Calder\u00f3n-Castrat X, Bancalari-D\u00edaz D, Rom\u00e1n-Curto C, Romo-Melgar A, Amor\u00f3s-Cerd\u00e1n D, Alcaraz-Mas LA et al (2016) PSTPIP1 gene mutation in a\u00a0pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br J Dermatol 175:194\u2013198. \n                    https:\/\/doi.org\/10.1111\/bjd.14383","journal-title":"Br J Dermatol"},{"key":"4312_CR10","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1182\/blood-2013-07-516948","volume":"123","author":"TW Starnes","year":"2014","unstructured":"Starnes TW, Bennin DA, Bing X, Eickhoff JC, Grahf DC, Bellak JM et al (2014) The F\u2011BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood 123:2703\u20132714. \n                    https:\/\/doi.org\/10.1182\/blood-2013-07-516948","journal-title":"Blood"},{"key":"4312_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig T, Henao-Mejia J, Elinav E, Flavell R (2012) Inflammasomes in health and disease. Nature 481:278\u2013286. \n                    https:\/\/doi.org\/10.1038\/nature10759","journal-title":"Nature"},{"key":"4312_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","volume":"66","author":"M Braun-Falco","year":"2012","unstructured":"Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T (2012) Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)\u2014a new autoinflammatory syndrome distinct from PAPA syndrome. J\u00a0Am Acad Dermatol 66:409\u2013415. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2010.12.025","journal-title":"J Am Acad Dermatol"},{"key":"4312_CR13","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/art.34332","volume":"64","author":"AP Demidowich","year":"2012","unstructured":"Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML et\u00a0al (2012) Brief report: Genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum 64:2022\u20132027. \n                    https:\/\/doi.org\/10.1002\/art.34332","journal-title":"Arthritis Rheum"},{"key":"4312_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s15010-017-0996-1","volume":"45","author":"W L\u00f6ffler","year":"2017","unstructured":"L\u00f6ffler W, Lohse P, Weihmayr T, Widenmayer W (2017) Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: Differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts. Infection 45:395\u2013402. \n                    https:\/\/doi.org\/10.1007\/s15010-017-0996-1","journal-title":"Infection"},{"key":"4312_CR15","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/rheumatology\/kei178","volume":"45","author":"B Tallon","year":"2006","unstructured":"Tallon B, Corkill M (2006) Peculiarities of PAPA syndrome. Rheumatology 45:1140\u20131143. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kei178","journal-title":"Rheumatology"},{"key":"4312_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000343602","volume":"225","author":"AV Marzano","year":"2012","unstructured":"Marzano AV, Ishak RS, Colombo A, Caroli F, Crosti C (2012) Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Dermatology 225:215\u2013219. \n                    https:\/\/doi.org\/10.1159\/000343602","journal-title":"Dermatology"},{"key":"4312_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.12659\/AJCR.898027","volume":"17","author":"MA Ursani","year":"2016","unstructured":"Ursani MA, Appleyard J, Whiteru O (2016) Pyogenic arthritis, pyoderma gangrenosum, acne, suppurative Hidradenitis (PA-PASH) syndrome: an atypical presentation of a\u00a0rare syndrome. Am J Case Rep 17:587\u2013591","journal-title":"Am J Case Rep"},{"key":"4312_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et\u00a0al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 411:603\u2013606. \n                    https:\/\/doi.org\/10.1038\/35079114","journal-title":"Nature"},{"key":"4312_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H, Lesage S, C\u00e9zard JP, Belaiche J et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 411:599\u2013603. \n                    https:\/\/doi.org\/10.1038\/35079107","journal-title":"Nature"},{"key":"4312_CR20","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1111\/jdv.12765","volume":"29","author":"J Staub","year":"2015","unstructured":"Staub J, Pfannschmidt N, Strohal R, Braun-Falco M, Lohse P, Goerdt S, Leverkus M (2015) Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. J\u00a0Eur Acad Dermatol Venereol 29:2243\u20132247. \n                    https:\/\/doi.org\/10.1111\/jdv.12765","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4312_CR21","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/annrheumdis-2015-207701","volume":"75","author":"M Rusmini","year":"2016","unstructured":"Rusmini M, Federici S, Caroli F, Grossi A, Baldi M, Obici L et al (2016) Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. Ann Rheum Dis 75:1550\u20131557. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2015-207701","journal-title":"Ann Rheum Dis"},{"key":"4312_CR22","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/bjd.15226","volume":"176","author":"AV Marzano","year":"2017","unstructured":"Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M (2017) Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol 176:1588\u20131598. \n                    https:\/\/doi.org\/10.1111\/bjd.15226","journal-title":"Br J Dermatol"},{"key":"4312_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jdcr.2016.11.006","volume":"3","author":"D Niv","year":"2017","unstructured":"Niv D, Ramirez JA, Fivenson DP (2017) Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis. JAAD Case Rep 3:70\u201373. \n                    https:\/\/doi.org\/10.1016\/j.jdcr.2016.11.006","journal-title":"JAAD Case Rep"},{"key":"4312_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00124743-200210000-00009","volume":"8","author":"AF Edrees","year":"2002","unstructured":"Edrees AF, Kaplan DL, Abdou NI (2002) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels. J\u00a0Clin Rheumatol 8:273\u2013275","journal-title":"J Clin Rheumatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4312-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:19:27Z","timestamp":1574363967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4312"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4312-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"assertion":[{"value":"22 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Sch\u00e4ffler, T.\u00a0Blattmann, A.\u00a0Findeisen, F.G.\u00a0Meinel, A.\u00a0Meyer-Bahlburg, G.\u00a0Lamprecht, L.\u00a0Steinm\u00fcller-Magin, R.\u00a0Trauzeddel und S.\u00a0Emmert geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Falle von nicht m\u00fcndigen Patienten liegt die Einwilligung eines Erziehungsberechtigten oder des gesetzlich bestellten Betreuers vor. Alle im vorliegenden Manuskript beschriebenen Untersuchungen am Menschen wurden mit Zustimmung der zust\u00e4ndigen Ethik-Kommission, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Von allen beteiligten Patienten liegt eine Einverst\u00e4ndniserkl\u00e4rung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}